Intracardiac J-point elevation before the onset of polymorphic ventricular tachycardia and ventricular fibrillation in patients with an implantable cardioverter-defibrillator.
Intracardiac J-point elevation before the onset of polymorphic ventricular tachycardia and ventricular fibrillation in patients with an implantable cardioverter-defibrillator.
复制标题
DOI:
10.1016/j.hrthm.2012.06.036
复制
发表时间:
2012-10
期刊:
影响因子:
5.5
通讯作者:
Berger, Ronald D.
中科院分区:
文献类型:
--
作者:
Tereshchenko, Larisa G.;McCabe, Aaron;Han, Lichy;Sur, Sanjoli;Huang, Timothy;Marine, Joseph E.;Cheng, Alan;Spragg, David D.;Sinha, Sunil;Calkins, Hugh;Stein, Kenneth;Tomaselli, Gordon F.;Berger, Ronald D.
关键词:
The clinical importance of the J-point elevation on ECG is controversial. Study intracardiac J-point amplitude before ventricular arrhythmia. Baseline 12-lead ECGs and far-field (FF) right ventricular (RV) intracardiac ICD electrograms (EGMs) were recorded at rest in 494 patients [mean age 60.4±13.1; 360 (72.9%) men] with structural heart disease [278 (56.3%) ischemic cardiomyopathy] who received primary [463 (93.9%) patients] or secondary prevention ICD. Ten-second intracardiac FF EGMs before the onset of arrhythmia were compared with the baseline. The J-point amplitude was measured on the baseline 12-lead surface ECG and the intracardiac FF EGM. The relative J-point amplitude was calculated as the ratio of J-point amplitude to peak-to-peak R-wave. The paired t-test showed that the relative intracardiac J-point amplitude was significantly higher before polymorphic ventricular tachycardia (PVT)/ventricular fibrillation (VF) onset (0.28±0.08 vs. −0.19±0.39; p=0.012) than at baseline. In a mixed-effects logistic regression model, adjusted for multiple episodes per patient, each 10% increase in relative J-point amplitude increased the odds of having VT/VF by 13% [OR 1.13 (95% CI 1.07–1.19); P<0.0001] and increased the odds of having PVT/VF by 27% [OR 1.27 (95% CI 1.11–1.46); P=0.001]. The relative intracardiac J-point amplitude is augmented immediately before the onset of PVT/VF in patients with structural heart disease.
登录
查看更多内容
影响因子:
5.5
作者:
Tereshchenko, Larisa G.;Han, Lichy;Cheng, Alan;Marine, Joseph E.;Spragg, David D.;Sinha, Sunil;Dalal, Darshan;Calkins, Hugh;Tomaselli, Gordon F.;Berger, Ronald D.
通讯作者:
Berger, Ronald D.
影响因子:
5.5
作者:
Shinohara, Tetsuji;Takahashi, Naohiko;Yoshimatsu, Hironobu
通讯作者:
Yoshimatsu, Hironobu
影响因子:
1.9
作者:
Rabe-Hesketh, S.;Skrondal, A.;Gjessing, H. K.
通讯作者:
Gjessing, H. K.
影响因子:
24
作者:
Fischell, Tim A.;Fischell, David R.;Gibson, C. Michael
通讯作者:
Gibson, C. Michael
影响因子:
4.6
作者:
Requena-Carrion, Jesus;Vaisanen, Juho;Luis Rojo-Alvarez, Jose
通讯作者:
Luis Rojo-Alvarez, Jose